Skip to main content
Proteome Science logoLink to Proteome Science
. 2020 Oct 24;18:9. doi: 10.1186/s12953-020-00166-4

Correction to: Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia

Ju Bai 1, Aili He 1,, Chen Huang 2, Juan Yang 2, Wanggang Zhang 1,, Jianli Wang 1, Yun Yang 1, Pengyu Zhang 1, Yang Zhang 1, Fuling Zhou 1
PMCID: PMC7585291  PMID: 33110398

Correction to: Proteome Sci (2014) 12:49

https://doi.org/10.1186/s12953-014-0049-y

Following publication of the original article [1], the authors reported an error in Fig. 9, the western-blot bands of PF4 were not correct.

Fig. 9.

Fig. 9

Validation of proteins by immunoblotting. a Levels of the FGA and GSTP1 protein differ among the leukemia cells in distinct ALL groups and normal cells. Weak PF4 immunoreactive bands are seen in newly diagnosed and refractory & relapsed ALL cases. b Densitometry comparison of FGA protein relative to β-actin as determined by western blot analysis in figure a. c Densitometry comparison of GSTP1 protein relative to β-actin as determined by western blot analysis in figure a. d Densitometry comparison of PF4 protein relative to β-actin as determined by western blot analysis in figure a. (FGA: fibrinogen alpha chain; GSTP1: glutathione S-transferase P1; PF4: platelet factor 4; ALL- CR: ALL complete remission; ALL-ND: ALL newly diagnosed; ALL-RR: ALL refractory & relapsed)

The correct Fig. 9 is shown below.

Contributor Information

Aili He, Email: heaili@mail.xjtu.edu.cn.

Wanggang Zhang, Email: zhangwanggang2003@yahoo.com.

Reference

  • 1.Bai J, He A, Huang C, et al. Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia. Proteome Sci. 2014;12:49. doi: 10.1186/s12953-014-0049-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proteome Science are provided here courtesy of BMC

RESOURCES